Sodium in PDB 6lp6: Crystal Structure of Human Dhodh in Complex with Inhibitor 1214
Enzymatic activity of Crystal Structure of Human Dhodh in Complex with Inhibitor 1214
All present enzymatic activity of Crystal Structure of Human Dhodh in Complex with Inhibitor 1214:
1.3.5.2;
Protein crystallography data
The structure of Crystal Structure of Human Dhodh in Complex with Inhibitor 1214, PDB code: 6lp6
was solved by
Q.Chen,
Y.Yu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
37.38 /
1.80
|
Space group
|
P 32 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
90.605,
90.605,
123.057,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
15.5 /
17.8
|
Other elements in 6lp6:
The structure of Crystal Structure of Human Dhodh in Complex with Inhibitor 1214 also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1214
(pdb code 6lp6). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 3 binding sites of Sodium where determined in the
Crystal Structure of Human Dhodh in Complex with Inhibitor 1214, PDB code: 6lp6:
Jump to Sodium binding site number:
1;
2;
3;
Sodium binding site 1 out
of 3 in 6lp6
Go back to
Sodium Binding Sites List in 6lp6
Sodium binding site 1 out
of 3 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1214
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1214 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na412
b:28.2
occ:1.00
|
O
|
A:ACT405
|
2.6
|
32.0
|
1.0
|
O
|
A:HOH563
|
2.8
|
14.5
|
1.0
|
HG3
|
A:GLN165
|
2.8
|
30.5
|
1.0
|
O
|
A:GLN165
|
2.8
|
15.2
|
1.0
|
O
|
A:HOH640
|
2.8
|
28.4
|
1.0
|
HB3
|
A:GLN168
|
2.8
|
17.5
|
1.0
|
C
|
A:ACT405
|
3.2
|
46.5
|
1.0
|
OXT
|
A:ACT405
|
3.4
|
44.2
|
1.0
|
HG2
|
A:GLN165
|
3.4
|
30.5
|
1.0
|
HA
|
A:GLN165
|
3.5
|
16.1
|
1.0
|
HB2
|
A:ALA169
|
3.5
|
25.2
|
1.0
|
H
|
A:ALA169
|
3.5
|
20.7
|
1.0
|
CG
|
A:GLN165
|
3.5
|
25.4
|
1.0
|
HG3
|
A:GLN168
|
3.7
|
16.6
|
1.0
|
N
|
A:ALA169
|
3.7
|
17.2
|
1.0
|
CB
|
A:GLN168
|
3.7
|
14.6
|
1.0
|
C
|
A:GLN165
|
3.7
|
20.5
|
1.0
|
HG2
|
A:GLN168
|
3.8
|
16.6
|
1.0
|
HA
|
A:ALA169
|
3.8
|
23.9
|
1.0
|
CG
|
A:GLN168
|
3.9
|
13.8
|
1.0
|
HE21
|
A:GLN165
|
4.0
|
37.3
|
1.0
|
CA
|
A:GLN165
|
4.0
|
13.4
|
1.0
|
CA
|
A:ALA169
|
4.1
|
19.9
|
1.0
|
C
|
A:GLN168
|
4.2
|
17.3
|
1.0
|
H3
|
A:ACT405
|
4.2
|
51.6
|
1.0
|
CB
|
A:ALA169
|
4.2
|
21.0
|
1.0
|
HA
|
A:LEU205
|
4.3
|
17.2
|
1.0
|
CH3
|
A:ACT405
|
4.3
|
43.0
|
1.0
|
HB2
|
A:GLN168
|
4.4
|
17.5
|
1.0
|
CB
|
A:GLN165
|
4.4
|
21.2
|
1.0
|
O
|
A:LEU205
|
4.4
|
16.3
|
1.0
|
CA
|
A:GLN168
|
4.5
|
16.3
|
1.0
|
HD23
|
A:LEU205
|
4.5
|
25.9
|
1.0
|
NE2
|
A:GLN165
|
4.6
|
31.1
|
1.0
|
O
|
A:HOH681
|
4.6
|
36.2
|
1.0
|
CD
|
A:GLN165
|
4.6
|
33.2
|
1.0
|
H
|
A:GLN168
|
4.7
|
21.3
|
1.0
|
HB3
|
A:ALA169
|
4.8
|
25.2
|
1.0
|
HA
|
A:GLN166
|
4.8
|
23.8
|
1.0
|
O
|
A:GLN168
|
4.9
|
16.1
|
1.0
|
HB1
|
A:ALA169
|
4.9
|
25.2
|
1.0
|
HB2
|
A:GLN165
|
4.9
|
25.5
|
1.0
|
N
|
A:GLN166
|
4.9
|
19.4
|
1.0
|
O
|
A:HOH643
|
4.9
|
14.9
|
1.0
|
C
|
A:LEU205
|
5.0
|
17.0
|
1.0
|
H1
|
A:ACT405
|
5.0
|
51.6
|
1.0
|
N
|
A:GLN168
|
5.0
|
17.8
|
1.0
|
|
Sodium binding site 2 out
of 3 in 6lp6
Go back to
Sodium Binding Sites List in 6lp6
Sodium binding site 2 out
of 3 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1214
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1214 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na413
b:34.9
occ:1.00
|
H
|
A:GLN263
|
2.2
|
19.5
|
1.0
|
H3
|
A:ACT408
|
2.3
|
58.8
|
1.0
|
HB
|
A:THR261
|
2.5
|
24.5
|
1.0
|
H1
|
A:ACT408
|
2.6
|
58.8
|
1.0
|
CH3
|
A:ACT408
|
2.8
|
49.0
|
1.0
|
HB2
|
A:GLN263
|
2.9
|
29.9
|
1.0
|
O
|
A:ACT411
|
2.9
|
54.2
|
1.0
|
N
|
A:GLN263
|
3.1
|
16.3
|
1.0
|
HB2
|
A:SER262
|
3.1
|
33.3
|
1.0
|
H
|
A:SER262
|
3.2
|
24.7
|
1.0
|
HB3
|
A:GLN263
|
3.2
|
29.9
|
1.0
|
C
|
A:ACT408
|
3.3
|
58.5
|
1.0
|
CB
|
A:THR261
|
3.4
|
20.4
|
1.0
|
CB
|
A:GLN263
|
3.4
|
24.9
|
1.0
|
N
|
A:SER262
|
3.5
|
20.6
|
1.0
|
HG1
|
A:THR261
|
3.6
|
28.3
|
1.0
|
O
|
A:ACT408
|
3.6
|
38.3
|
1.0
|
OG1
|
A:THR261
|
3.7
|
23.6
|
1.0
|
C
|
A:ACT411
|
3.8
|
38.1
|
1.0
|
H2
|
A:ACT408
|
3.8
|
58.8
|
1.0
|
CA
|
A:GLN263
|
3.8
|
21.0
|
1.0
|
CB
|
A:SER262
|
3.9
|
27.7
|
1.0
|
C
|
A:SER262
|
4.0
|
15.4
|
1.0
|
CA
|
A:SER262
|
4.0
|
18.4
|
1.0
|
OXT
|
A:ACT408
|
4.1
|
76.5
|
1.0
|
C
|
A:THR261
|
4.1
|
23.8
|
1.0
|
HG21
|
A:THR261
|
4.2
|
31.1
|
1.0
|
CA
|
A:THR261
|
4.3
|
21.9
|
1.0
|
HA
|
A:GLN263
|
4.3
|
25.2
|
1.0
|
CG2
|
A:THR261
|
4.3
|
26.0
|
1.0
|
CH3
|
A:ACT411
|
4.4
|
21.6
|
1.0
|
HA
|
A:THR261
|
4.4
|
26.2
|
1.0
|
H
|
A:ASP264
|
4.5
|
21.4
|
1.0
|
HB3
|
A:SER262
|
4.5
|
33.3
|
1.0
|
HG22
|
A:THR261
|
4.5
|
31.1
|
1.0
|
OXT
|
A:ACT411
|
4.6
|
67.4
|
1.0
|
OG
|
A:SER262
|
4.8
|
36.5
|
1.0
|
CG
|
A:GLN263
|
4.8
|
27.7
|
1.0
|
HG2
|
A:GLN263
|
4.9
|
33.3
|
1.0
|
HA
|
A:SER262
|
5.0
|
22.1
|
1.0
|
|
Sodium binding site 3 out
of 3 in 6lp6
Go back to
Sodium Binding Sites List in 6lp6
Sodium binding site 3 out
of 3 in the Crystal Structure of Human Dhodh in Complex with Inhibitor 1214
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Crystal Structure of Human Dhodh in Complex with Inhibitor 1214 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na414
b:51.9
occ:1.00
|
O
|
A:HOH697
|
2.4
|
49.8
|
1.0
|
O
|
A:HOH516
|
2.8
|
34.1
|
1.0
|
H1
|
A:ACT405
|
3.3
|
51.6
|
1.0
|
O
|
A:HOH547
|
3.4
|
15.8
|
1.0
|
HA
|
A:ASP207
|
3.5
|
13.2
|
1.0
|
O
|
A:ARG249
|
3.5
|
18.2
|
1.0
|
HA
|
A:PRO250
|
3.5
|
20.3
|
1.0
|
H
|
A:ARG249
|
3.9
|
20.5
|
1.0
|
O
|
A:ALA206
|
3.9
|
17.2
|
1.0
|
O
|
A:VAL247
|
3.9
|
26.1
|
1.0
|
C
|
A:ARG249
|
3.9
|
17.9
|
1.0
|
HE1
|
A:HIS86
|
4.1
|
35.1
|
1.0
|
O
|
A:HOH681
|
4.1
|
36.2
|
1.0
|
N
|
A:ARG249
|
4.2
|
17.1
|
1.0
|
OD1
|
A:ASP207
|
4.2
|
19.0
|
1.0
|
NE2
|
A:HIS86
|
4.3
|
22.4
|
1.0
|
CA
|
A:PRO250
|
4.3
|
16.9
|
1.0
|
HA
|
A:HIS248
|
4.3
|
20.8
|
1.0
|
CH3
|
A:ACT405
|
4.4
|
43.0
|
1.0
|
N
|
A:PRO250
|
4.4
|
15.0
|
1.0
|
CA
|
A:ASP207
|
4.4
|
11.0
|
1.0
|
CE1
|
A:HIS86
|
4.5
|
29.3
|
1.0
|
C
|
A:VAL247
|
4.6
|
27.1
|
1.0
|
O
|
A:ASP207
|
4.6
|
13.6
|
1.0
|
HB3
|
A:PRO250
|
4.6
|
19.4
|
1.0
|
C
|
A:HIS248
|
4.6
|
15.5
|
1.0
|
H3
|
A:ACT405
|
4.7
|
51.6
|
1.0
|
CA
|
A:ARG249
|
4.7
|
16.1
|
1.0
|
H2
|
A:ACT405
|
4.8
|
51.6
|
1.0
|
C
|
A:ALA206
|
4.8
|
14.9
|
1.0
|
CA
|
A:HIS248
|
4.8
|
17.3
|
1.0
|
C
|
A:ASP207
|
5.0
|
12.0
|
1.0
|
N
|
A:HIS248
|
5.0
|
19.5
|
1.0
|
|
Reference:
Z.Zuo,
X.Liu,
X.Qian,
T.Zeng,
N.Sang,
H.Liu,
Y.Zhou,
L.Tao,
X.Zhou,
N.Su,
Y.Yu,
Q.Chen,
Y.Luo,
Y.Zhao.
Bifunctional Naphtho[2,3- D ][1,2,3]Triazole-4,9-Dione Compounds Exhibit Antitumor Effects in Vitro and in Vivo By Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production. J.Med.Chem. V. 63 7633 2020.
ISSN: ISSN 0022-2623
PubMed: 32496056
DOI: 10.1021/ACS.JMEDCHEM.0C00512
Page generated: Tue Oct 8 11:44:23 2024
|